Medical Services Principal Secretary Dr. Ouma Oluga on Friday, September 19 called on global investors in the healthcare sector to consider Kenya as their destination of choice.
Speaking durung a high-level breakfast event organised by Kenya Vision 2030 in partnership with Dalberg, PS Oluga cited Kenya’s unique opportunities and growing competitiveness as the incentive why gloabl investors should scramble for Kenya.
According to Oluga, Kenya’s ambition is to become Africa’s foremost hub for vaccine and pharmaceutical manufacturing.
He emphasised the government’s commitment, highlighting the establishment and investment in the Kenya Biovax Institute as a flagship initiative that demonstrates Kenya’s determination to build local capacity for the production of vaccines and essential medicines.
“Kenya is ready to partner with investors to build a resilient healthcare ecosystem that not only serves our nation but positions us as a continental leader in pharmaceutical innovation and supply security,” Dr Oluga said.
The event brought together policymakers, healthcare leaders, and international investors in Washington D.C., underscoring Kenya’s strong drive to attract strategic partnerships that will accelerate progress towards Universal Health Coverage (UHC) and enhance the country’s contribution to Africa’s health security.
